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Abstract
Background: Preterm birth is a health and social problem, considered the leading cause of neonatal mortality
worldwide. It is associated with higher rates of neurodevelopmental morbidity, sensorineural impairments and other
complications. The aim of the study was to describe the incidence and the major risk factors associated with
preterm birth.
Methods: We performed a single center, observational and retrospective Cohort study in the Division of Obstetrics
and Gynaecology, University Hospital “G. Martino”, Messina. Clinical records of all pregnant women who delivered
from 1st January 2010 to 31 of December 2016 were collected.
Results: In the 7 years considered, a total of 7954 pregnant women were included in our study. The majority of all
preterm births were due to infants born late preterm (71.83%), 26.45% were due to preterm and 1.72% to extremely
preterm. The preterm cohort had a higher proportion of history of preterm delivery (p< 0.0001), and unmarried (p= 0.003)
and underweight or obese patients (p< 0.0001). In addition, prematurity was associated with presence of uterine anomalies
(p< 0.0001), vaginal/urinary infections (p= 0.02), poli/oligohydramnios (p< 0.0001), maternal diabetes (p= 0.004),
hypertension (p < 0.0001), short cervical length (p < 0.0001).
Conclusions: We suggest prompt identification of all risk factors associated with preterm birth to apply immediate and
appropriate specific interventions.
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Background
Preterm birth (PTB) is a serious health and social prob-
lem, considered the leading cause of neonatal mortality
worldwide [1, 2]. It is associated with higher rates of
neurodevelopmental morbidity, sensorineural impair-
ments and other complications of the respiratory,
gastrointestinal and renal systems. Epidemiologic evi-
dence also suggests that preterm babies have a signifi-
cantly increased risk of many chronic degenerative
diseases in adulthood, including coronary heart disease,
stroke, hypertension, and type II diabetes mellitus [3].
The incidence rates are higher in underdeveloped
countries (11.8%) compared to those most developed
(9.3%) [4]. The high incidence of this condition even in
most developed countries is due to the fact that even
though the incidence of preterm delivery is decreasing
for greater prevention of known risk factors, it is also in-
creasing due to iatrogenic PTB [5], an improvement of
reproductive technology with, consequently, multiple
gestations and also an increased maternal age [6].
According to World Health Organization (WHO), pre-
term birth is defined as any birth before 37 completed
weeks of gestation [7]. A decreasing gestational age is as-
sociated with increasing complications for premature ba-
bies. The gestational age cut off used to distinguish a
PTB from spontaneous abortion varies by geographic
areas. In our study the cut off considered is 21 weeks
and 5 days, as suggested by “Florence Card” in 2008 [8]
and reported in the protocol of our Hospital. In the US,
for example, 20 weeks is used as the lower gestational
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age limit [9], while in other regions, especially lower and
middle income countries, 28 weeks is often used as the
lower limit [9]. We must therefore consider the lower
gestational age cut off when we compare PTB rates
between different geographic areas.
The research carried out and the preventive measures
adopted in this field over the years have allowed a reduc-
tion of the incidence of PTB demonstrating the import-
ance of identifying the risk factors associated with this
condition [10].
The aim of this study was to assess the trend of the in-
cidence of preterm birth and the major risk factors,
combining both maternal risk factors (RFs) and cervical
length (CL) and with the inclusion in our cohort of
women with a history of previous PTB.
Methods
We performed a single center, observational and retrospect-
ive Cohort study in the Division of Obstetrics and Gynae-
cology, University Hospital “G. Martino”, Messina,
Italy. As a standard protocol, each patient, on admis-
sion, signed an informed consent allowing data col-
lection for research purposes. The study design was
in accordance with the Helsinki Declaration and was
approved by the Institutional Review Board of the
University Hospital involved. All the design, analysis,
interpretation of data, drafting and revisions followed
the guidelines for reporting observational studies
(STROBE) [11], available through the EQUATOR
(Enhancing the QUAlity and Transparency Of health
Research) network (http://www.equatornetwork.org/).
Clinical records of all pregnant women who delivered
from 1st January 2010 to 31 of December 2016 were col-
lected, while patients who underwent cerclage, pregnan-
cies complicated by intrauterine fetal death or serious
fetal malformation and multiple pregnancies have been
excluded (Table 1).
We defined preterm birth all the deliveries before 36
+ 6/7 week/day of gestation according to the WHO [7].
We planned to look at subgroups of PTBs, such as ex-
tremely early preterm (i.e. 21 + 5–23 + 6), preterm (i.e.
24–33 + 6) and late preterm (i.e. 34–36 + 6) [12].
Statistical analysis
Statistical analysis was conducted using SAS version 9.2
(SAS Institute Inc., Cary, NC, USA). Continuous vari-
ables are presented as mean (SD) or median (interquar-
tile range), where appropriate, and categorical variables
as frequencies and percentages. Differences between
control and preterm cases were assessed using unpaired
Student’s t-tests or Mann–Whitney U test, as appropri-
ate. The chi-square test was used to compare frequen-
cies. Bivariate associations were tested by Spearman
correlation. A conservatively adjusted a priori alpha was
set at p < .01 due to multiple comparisons.
Results
A total of 8179 pregnant women were admitted to de-
liver in our Institution in the period considered [Fig. 1a].
Seven thousand nine hundred fifty-four cases were in-
cluded in our study and 225 were excluded as they did
not fall within the inclusion criteria. The preterm cases
were 639 (7.8%). Demographic and clinical characteris-
tics of the preterm cohort and the term controls are
shown in Table 1.
The rate of preterm birth in our Institution has shown
a relatively stable or a slightly decreasing trend from 7.2
to 6.9% over the 7 year period (Fig. 1b).
The majority of all preterm births were due to infants
born late preterm, 71.83% (n = 459), 26,45% (n = 169)
were due to preterm and 1.72% (n = 11) to extremely
preterm (Fig. 2).
The preterm cohort showed a higher proportion of history
of a prior spontaneous PTB (p < 0.0001), unmarried women
(p= 0.003) and underweight or obese patients (p < 0.0001).
In addition, PTB was associated with presence of uterine
anomalies (p < 0.0001), vaginal/urinary infections (p= 0.02),
poli-oligodramnios (p < 0.0001), maternal diabetes
(p = 0.004) and hypertension (p < 0.0001).
The median value of cervical length measured from
16th to 24th week of pregnancy was 31mm in cases
who delivered preterm and 38mm in controls, demon-
strating a significant difference between the two groups
(p < 0.0001) (Table 1 e Fig. 2). The CL measurement,
using a cut off of 25 mm according to the SIEOG guide-
lines (28), showed a sensibility of 78%, demonstrating to
be an adequate screening test for the women at risk of
PTB, even if the specificity was only 3%.
Among PTB, cervical length positively correlated with
gestational age (r = 0.42, p < 0.0001) (Fig. 2). A sub-analysis
of preterm birth categories based on gestational age showed
a stronger correlation between gestational age and cervical
length among preterm and extremely preterm (r = 0.50, p =
0.0002), while no correlation was found among late preterm
(r = 0.01, p = 0.85). Among PTB, cervical length correlated
with older mothers (r = 0.21, p = 0.025). No other correla-
tions were found.
Discussion
In our observational and retrospective Cohort study of
pregnant women admitted to an Obstetric Department
in Southern Italy, the incidence of preterm birth was
7.8%. The rate of preterm birth decreased from 7.2 to
6.9% (Fig. 1b), together with an increase of births in our
Hospital (Fig. 1a). However, the value remains high, con-
sidering that preterm birth is associated with most of
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Fig. 1 a Trends of annual births in our Institution. b Trends of preterm birth annual cases in our Institution
Table 1 Clinical and demographic characteristics of control and preterm cases
Characteristics Controls (n = 7315) Preterm Cases (n = 639) p-value
Maternal age (years), mean (SD) 31.87 (6.04) 31.68 (5.65) 0.025
Pre-pregnancy weight (kg), mean (SD) 63.44 (13.98) 63.73 (13.32) 0.2
Maternal BMI, n (%) Underweight 293 (4) 102 (16) < 0.0001*
Normal 4462 (61) 262 (41)
Overweight 1682 (23) 51 (8)
Obesity 878 (12) 224 (35)
Marital status, n (%) Married 5998 (82) 492 (77) 0.003*
Unmarried 1317 (18) 147 (23)
Parity Nulliparous 4096 (56) 367 (57.5) 0.5
Parous 3219 (44) 272 (42.5)
Prior history of PTB, Yes/No, n (%) 256/7059 (3.5/96.5) 40/428 (8.5/91.5) < 0.0001*
Treatment for cervical dysplasia
Yes/No, n (%) 110/ 7205 (1.5/98.5) 13/626 (2/98) 0.2
Cervical Length (mm), median (IQR) 38 (34–42) 31 (23–37) < 0.0001*
Uterine Anomalies, Yes/No, n (%) 66/7249 (0.9/99.1) 22/617 (3.4/96.6) < 0.0001*
Vaginal/Urinary Infections Yes/No, n (%) 1463/5852 (20/80) 115/524 (18/82) 0.02*
Poly/oligohydramnios
Yes/No, n (%) No 7096 (97) 518 (81) < 0.0001*
Polyhydramnios 37 (0.5) 13 (2)
Oligohydramnios 182 (2.5) 102 (9)
Hypertension, Yes/No, n (%) 366/6949 (5/95) 115/524 (18/82) < 0.0001*
Thyroid disease, Yes/No, n (%) 1024/6291 (14/86) 83/556 (13/87) 0.5
Diabetes, Yes/No, n (%) 732/6583 (10/90) 93/546 (14.5/85.5) 0.004*
Maternal Surgery, Yes/No, n (%) 2677/4638 (36.6/63.4) 252/387 (39.5/60.5) 0.2
Psychological Disorders, Yes/No, n (%) 37/7278 (0.5/99.5) 7/632 (1.1/98.9) 0.3
Smoking, Yes/No, n (%) 658/6657 (9/91) 51/588 (8/92) 0.5
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the pregnancy-related mortality and and short and
long-term disability [2].
The slightly decreasing rate of PTB could be, partially, ex-
plained with the utmost attention in the prevention of this
condition based on the known risk factors. Many features
are associated with PTB, such as maternal demographic
characteristics [6], nutritional status/ physical activity, prior
ob/gyn history, current pregnancy characteristics (i.e. vagi-
nal bleeding, uterine contractions, poly/oligohydramnios,
psychological problems, use of drugs or infection) [13–16].
Among these risk factors, history of PTB and short CL are
considered the most important predictive factors [17–20].
Particularly, a short cervix in the second trimester (i.e. a
cervix measure < 15mm, in a single pregnancy) [21] is a
powerful predictor of spontaneous PTB, regardless of ob-
stetrical history [22].
In our analysis, we only included data on risk factors,
which were clearly reported in all clinical records or sig-
nificantly present in the folders. We report a significant
association between PTB and risk factors such as vagi-
nal/urinary infections, underweight or obese patients,
unmarried status, the presence of uterine anomalies,
poly/oligohydramnios, hypertension, diabetes, a history
of PTB and, finally, a short cervical length. Many of
these risk factors could be identified with a good medical
history and also treated, leading to an improvement of
the risk at the beginning of pregnancy.
In our study, particular attention has been given to CL
measurement. While “late preterm” cases demonstrated
a large variability of CL values, the “preterm” and “very
early” preterm cases were more correlated with short
cervical length, independently to a history of previous
preterm. This data, confirming previous studies [23], as-
sumes that cervical length helps to identify better the
case at risk for early and very early PTB. Probably, in
late preterm cases, other risk factors should be also con-
sidered, such as maternal disease (i.e.: severe hyperten-
sion resistant to medical therapy) or fetal pathological
conditions which prompt the gynaecologist to induce
labor, determining an iatrogenic PTB.
Our findings suggest a universal cervical screening (i.e.
not only for women at higher risk) should be performed
in order to discover, at an early stage, asymptomatic
women with a short cervix (2–5% of total) [24] and to ad-
minister a preventive therapy [25, 26]. The CL measure-
ment could be taken during the midtrimester ultrasound
screening by all obstetric ultrasonographers who have re-
ceived appropriate training. Transvaginal ultrasound is
safe, and when performed by trained operators results are
reproducible with a relatively low inter-observer variation
rate of 5–10% [27]. Currently, the cervical measurement is
performed only in women with a higher risk of preterm
birth or with symptoms of preterm labour (to reduce
hospitalization for tocolysis) [28, 29], in women who
undergo cervical cerclage or in twin pregnancies [28].
Data on the utility of the cervical length measurement is
reported in many papers [23, 25, 28–31] but, according to
the guidelines of the Italian Society of Ultrasound in
Obstetrics and Gynaecology (SIEOG), the use of ultra-
sound for the evaluation of the uterine cervix in a low-risk
Fig. 2 Correlation between cervical length and gestation at birth in preterm cases and controls
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population is not supported by sufficient scientific evidence
[28]. This statement has been confirmed in the NICE (Na-
tional Institute for Health and Care Excellence) guideline
[32] and in the SCOG (Society of Obstetricians and Gynae-
cologists of Canada) guidelines, which do not consider the
consequent therapeutic interventions valid [33]. Cervical
screening is one tool that can be utilized to identify women
at increased risk in order to allow for interventions to pre-
vent, delay, or prepare for preterm births, without the need
to undergo to biochemical testing for specific markers for
preterm labour. Many authors have questioned if universal
midtrimester transvaginal CL screening meets the criteria
outlined by the WHO of an adequate screening test [34].
Some authors [35, 36] concluded that this screening for
women with a singleton gestation, followed by treatment
with vaginal progesterone for those with a short cervix,
meets all 10 criteria outlined by the WHO for endorsing the
implementation of a screening test in clinical medicine [34].
Also the recent Italian guidelines of the Confalonieri
Ragonese Foundation recommend performing a cervical
measurement during the second trimester ultrasound
screening (19–23.6 weeks) of all pregnant women and to ad-
minister 200mg of Progesterone to those women with a cer-
vix between 10 and 20mm [21]. This suggestion is
motivated by the results of a systematic review where it was
shown that Progesterone administration to a sample of
women without a history of PTB and with a cervix between
10 and 20mm demonstrated a significant reduction of PTB
and neonatal morbidity, while in the subgroup with a cer-
vical length < 10mm or between 21 and 25mm did not give
any benefits in prevention of PTB [37]. Another recent sys-
tematic review and meta-analysis [26] from randomised
controlled trials confirmed that vaginal progesterone was as-
sociated with a significant reduction in the risk of preterm
birth, respiratory distress syndrome, composite neonatal
morbidity and mortality, birth weight < 1500 and < 2500 g
and admission to the neonatal intensive care unit. The study
reported a reduction of about 40–50% of neonatal death, re-
spiratory distress syndrome, intraventricular haemorrhage
and proven neonatal sepsis. Moreover, maternal adverse
events, congenital anomalies and adverse neurodevelopmen-
tal and health outcomes at 2 years of age did not report any
difference between groups, confirming that vaginal proges-
teron is, at the same time, efficacious and safe [26].
We also use to administrate vaginal progesterone in all
the cases at risk for a short CL. This procedure has
probably contributed, together with all other preventive
measures, to the slight reduction of preterm birth over
the years in our Hospital.
Conclusions
Based on our results, we suggest prompt identification
of all risk factors associated with preterm birth to apply
immediate and appropriate specific interventions.
We also recommend, confirming the evidence of other
studies [26, 38–40], a transvaginal CL measurement dur-
ing the midtrimester ultrasound screening, in order to
identify the women most at risk who could benefit of a
progesterone therapy, without the need to undergo to fur-
thers biochemical testing for specific markers for PTB.
All these procedures could reduce the rate of PTB and
the associated neonatal morbidity and mortality.
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